TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Fri Apr 10

NL

Article

TMFBiologyFool published an article 4:52 PM

3 Potential Blockbuster Drugs That Could Be Approved Before Year's End

Our experts weigh in on some drug candidates with huge potential.

Thu Apr 9

NL

Article

TMFBiologyFool published an article 12:44 PM

3 Biotech Stocks That May Disappear Before 2020

Our experts weigh in.

Tue Apr 7

NL

Article

TMFBiologyFool published an article 1:36 PM

The Best Stock to Invest in Obesity Drugs

Making money helping people shed the pounds.

Sun Apr 5

NL

Article

TMFBiologyFool published an article 9:06 AM

3 Events That Could Sink the Biotech Sector This Year

Our experts weigh in.

Mon Mar 30

Thu Mar 26

NL

Article

TMFBiologyFool published an article 2:20 PM

Following Gilead Sciences, Inc., Which Biotech Will Pay a Dividend Next?

Our experts weigh in.

Thu Mar 19

NL

Article

TMFBiologyFool published an article 2:04 PM

3 Big Pharma Stocks Wall Street Is Wrong About

Three contributors weigh in.

Wed Mar 18

NL

Article

TMFBiologyFool published an article 3:15 PM

Confessions of a Value Investor Stuck in a High-Growth Industry

It's OK to buy premium-priced biotechs.

NL

Article

TMFBiologyFool published an article 1:46 PM

Best One-Drug Wonder Stock for 2015

You've got to start somewhere. Here's our top picks of biotechs with just one drug on the market.

Fri Mar 13

NL

Article

TMFBiologyFool published an article 5:47 PM

Orexigen Therapeutics, Inc. -- Stuck Between an Obese Rock and a Hard Place

The obesity drugmaker had good data that the FDA didn't want disclosed.

Tue Mar 10

NL

Article

TMFBiologyFool published an article 1:56 PM

3 Biotech Stocks to Buy If the Sector Crashes

Our experts recommend Alnylam Pharmaceuticals, Celgene, and Biogen Idec.

Mon Mar 9

NL

Article

TMFBiologyFool published an article 1:25 PM

3 Biotech Stocks to Buy in March

Our experts weigh in on why they like Vertex Pharmaceuticals, Neuralstem, and Intercept Pharmaceuticals.

Thu Mar 5

Rule Breakers article.

TMFBiologyFool published an update. 7:51 PM

NL

Article

TMFBiologyFool published an article 6:52 PM

Emergent Biosolutions Inc's Unexpected Surprise

With preannounced revenue and earnings, Emergent Biosolutions' fourth-quarter earnings were supposed to be boring.

NL

Article

TMFBiologyFool published an article 3:16 PM

3 Big Pharma Stocks to Buy in March

Our experts weigh in.

Tue Mar 3

NL

Article

TMFBiologyFool published an article 12:49 PM

3 Easy Ways to Fail When Investing in Biotech Stocks

Our experts help you avoid these common mistakes.

Mon Mar 2

NL

Article

TMFBiologyFool published an article 9:28 PM

5 Things MannKind Corporation's Management Wants You to Know

While info on Afrezza's launch was limited, some info on its next drugs flowed.

NL

Article

TMFBiologyFool published an article 8:24 PM

Arena Pharmaceuticals, Inc. Earnings: Explaining the Wonky Trends

A fourth-quarter slowdown and relatively flat sales over the year.

Rule Breakers article.

TMFBiologyFool published an update. 10:20 AM

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 97.07
Player Rank 2204 out of 75233
Score 1770.52
Score Change Today +81.86
Accuracy 67.79%
Active Picks 72
Total Picks 213
Best Pick MYL (+420.57)
Worst Pick INCY (-979.44)
Average Score per Pick 8.31
Charms Earned 11
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Three stars, 500 posts CAPS All Star
Board Posts 928
Recs Received 982
People who have rec'd these posts 380
Recs to Posts Ratio (last 30 days) N/A
Threads Started 90
Threads Started Percentage 9.70 %
Most Frequent Board Buying or Selling a Home
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 48.17 %
Show TMFBiologyFool’s 10 Latest Posts